NEW YORK (GenomeWeb News) – Roche today reported that its molecular diagnostics sales rose 5 percent and its applied science revenues increased 8 percent year over year for the first half of 2009.

The Swiss pharmaceuticals, diagnostics, and life sciences firm reported molecular diagnostic sales of CHF594 million (US$553.8 million), up 5 percent, while its applied science business brought in revenues of CHF 403 million, an increase of 8 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.